Extracellular Vesicle-Derived miRNA in Acute Myocardial Infarction

Announcing a new article publication for Cardiovascular Innovations and Applications journal. EV-miRNA-based precision diagnostics and targeted therapeutic strategies represent the frontier of personalized medicine. By integrating multi-omics data, developing highly sensitive molecular detection platforms, and advancing intelligent delivery systems, the continuum of prevention and management from Acute Myocardial Infarction to heart failure is progressively evolving into a comprehensive, multi-dimensional precision paradigm. This progress holds great promise for shifting clinical practice from population-based empirical treatments towards individualized, mechanism-driven therapies.

CVIA is available on the ScienceOpen platform and at Cardiovascular Innovations and Applications. Submissions may be made using ScholarOne Manuscripts. There are no author submission or article processing fees. Cardiovascular Innovations and Applications is indexed in the EMBASE, EBSCO, ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ, Index Copernicus, Research4Life and Ulrich’s web Databases. Follow CVIA on Twitter @CVIA_Journal; or Facebook.

Sha Hua, Hao Tian and Guoping Li. Extracellular Vesicle-Derived miRNA in Acute Myocardial Infarction. CVIA. 2025. Vol. 10(1). DOI: 10.15212/CVIA.2025.0026

CVIA Journal